Picket Fence Creamery ice cream and cheese curds were misbranded because labels did not declare ingredients and sub-ingredients.
What happened
The FDA inspected Picket Fence Creamery's food manufacturing facility on September 13-15, 2021. Investigators found twelve ice cream flavors and three cheese curd flavors contained undeclared ingredients and sub-ingredients. The firm made corrections to these issues but did not fully correct its product labels as noted in the letter.
What FDA found
Dutch Letter! Ice Cream labels named 'Dutch letters' and 'almond syrup' but did not list their sub-ingredients, such as flour, butter, eggs, and almond paste.
21 U.S.C. § 343(i)(2); 21 CFR 101.4Key Lime Pie! Ice Cream labels did not list the graham cracker or its sub-ingredients, the key lime pie filling sub-ingredients, or the lime syrup sub-ingredients.
21 U.S.C. § 343(i)(2); 21 CFR 101.4Taco! White Cheddar Cheese Curd labels stated 'taco seasoning' but did not list its sub-ingredients, and a revised contains statement listing only milk did not account for wheat flour in the seasoning.
21 U.S.C. § 343(i)(2); 21 CFR 101.4The Key Lime Pie! Ice Cream label placed colors in the 'contains' statement instead of listing them in descending order by amount.
21 CFR 101.4The labels did not include a Nutrition Facts label unless the product met an exemption.
21 CFR 101.9; 21 U.S.C. § 343(q)The revised labels did not include the firm's full street address.
21 CFR 101.5(d)
What FDA wants
FDA asks the company to notify it in writing within 15 working days of the specific steps taken to correct the violations and prevent recurrence, with supporting documents. If corrections cannot be finished in that time, the company must state why and when it will finish.
Who should pay attention
- ice cream and cheese curd makers that use multi-ingredient inclusions
- label reviewers and regulatory affairs teams at food companies
- retailers and consumers who rely on ingredient statements, including people with food allergies
This is a summary. Read the original letter on fda.gov.